X4 Pharmaceuticals, Inc. (XFOR) Capital expenditures 2022–2024
X4 Pharmaceuticals, Inc. (XFOR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$326,000FY2024 · since FY2022: $103,000 → $326,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $326,000 | +443.3% |
| FY2023 | $60,000 | -41.7% |
| FY2022 | $103,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice